Drug standards to be used for screening and ation of suspected drug use in service member and/or post-mortem urine, blood and tissue samples.
Ended Awarded
- Contract number
- HT009025FG0610020
- Awardee
-
Cerilliant Corporation UEI JDDKSJ34EBZ7
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $42,482
Award facts
- Contract value 100% obligated
- $42,481.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325199 All Other Basic Organic Chemical Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 2 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Round Rock, TX 78665, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency awarded a Blanket Purchase Agreement (BPA) call valued at approximately $42.5K to Cerilliant Corporation for drug standards to be used in screening and confirmation testing of suspected drug use in service member and post-mortem urine, blood, and tissue samples. The contract, awarded on June 18, 2025, with a completion date of September 30, 2025, is structured as a firm fixed-price arrangement with no set-aside designation. Performance will be conducted at Cerilliant's facility in Round Rock, Texas. This task order draws from one of Cerilliant's existing Defense Health Agency BPAs, leveraging the company's established expertise as a global leader in certified reference materials and chemical standards for federal laboratory and forensic applications.
Cerilliant Corporation specializes in manufacturing high-quality chemical and biological reference standards and laboratory supplies for defense and health-related organizations. The company maintains a substantial portfolio of federal contracts across multiple agencies, including the Defense Health Agency, Centers for Disease Control and Prevention, and National Institutes of Health, with performance locations primarily in Maryland and Texas. This award supports the Defense Health Agency's drug testing and toxicology screening programs for military personnel, providing critical certified reference materials necessary for accurate and reliable detection of controlled substances in forensic and medical testing contexts.
Quick answers
Who was awarded contract HT009025FG0610020?
HT009025FG0610020 was awarded to Cerilliant Corporation by Defense Health Agency (Department of Defense) on June 18, 2025.
How much is contract HT009025FG0610020 worth?
The government has obligated $42,482 on HT009025FG0610020.
Is contract HT009025FG0610020 an order under another contract?
Yes. HT009025FG0610020 is a BPA call under HT942523A0001, a blanket purchase agreement.
Was contract HT009025FG0610020 competed?
The extent of competition for HT009025FG0610020 was competed under sap. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award